March 21 at 1:21 p.m.
Filed under:
Litigation,
Pharmaceuticals
By Reuters
Mylan Inc. has sued the Food and Drug Administration to get generic versions of Pfizer Inc.’s Lipitor on the market in late June and block India’s Ranbaxy from receiving 180 days of marketing exclusivity for its version of the medicine.
Ranbaxy is expected to launch its generic Lipitor Nov. 30 under a settlement with Pfizer and remain free of multiple competitors for 180 days, as the first company to apply to sell a cheaper version of the world’s best selling prescription medicine. Get the full story »
Dec. 21, 2010 at 8:35 a.m.
Filed under:
Pharmaceuticals,
Recalls
By Associated Press
Pfizer is recalling a lot of 19,000 bottles of the blockbuster cholesterol drug Lipitor, citing a consumer complaint about an “uncharacteristic” odor.
The latest announcement marks the fourth such recall since August over similar issues. Pfizer says the bottles were supplied by an outside manufacturer, though it did not identify the party. It also says health consequences appear to be minimal. Get the full story »
Nov. 2, 2010 at 2:34 p.m.
Filed under:
Earnings,
M&A,
Pharmaceuticals
By Associated Press
Pharmaceutical giant Pfizer Inc.’s mega-acquisition of Wyeth boosted its third-quarter revenue 39 percent, but hefty charges and a higher tax rate, both related to that $68 billion purchase, dragged its profit down 70 percent, the company said Tuesday.
The New York-based maker of cholesterol blockbuster Lipitor and impotence pill Viagra posted net income of $866 million, or 11 cents per share. That’s down from $2.88 billion, or 43 cents per share, a year earlier. Get the full story »
Oct. 29, 2010 at 11:08 a.m.
Filed under:
Pharmaceuticals,
Recalls
By Reuters
Pfizer Inc. is recalling two more lots of its widely-used Lipitor cholesterol drug after chemicals from wooden pallets contaminated some bottles with an “uncharacteristic odor.” Get the full story »
Oct. 7, 2010 at 2:17 p.m.
Filed under:
Pharmaceuticals,
Recalls
By Reuters
Pfizer Inc. said it recalled 191,000 bottles of its top-selling Lipitor cholesterol fighter after reports of a musty odor coming from some bottles of the medicine made by a third-party supplier.
The world’s largest drugmaker said the recall, which took place in mid-August, involved seven lots of 40-milligram Lipitor, as well as three other lots of the medicine supplied to a Canadian generic drugmaker. Five of the seven recalled lots of the branded medicine were in the U.S., with two from Canada, Pfizer said. Get the full story »
